Related Experiment Video

Updated: May 1, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

1.8K

Extensively drug-resistant Streptococcus pneumoniae, South Korea, 2011-2012

Sun Young Cho, Jin Yang Baek, Cheol-In Kang

    Emerging Infectious Diseases
    |April 23, 2014
    PubMed

    Insights

    Extensively drug-resistant Streptococcus pneumoniae may be harbored by long-term care facility residents with tracheostomies. Consider pneumococcal vaccines for high-risk individuals and use antimicrobials cautiously.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Clinical Medicine

    Background:

    • Extensively drug-resistant Streptococcus pneumoniae (XDR-SP) poses a significant public health threat.
    • Understanding the clinical and microbiological features of XDR-SP is crucial for effective management.

    Purpose of the Study:

    • To investigate the clinical and microbiological characteristics of five extensively drug-resistant pneumococcal isolates.
    • To identify potential reservoirs and risk factors associated with XDR-SP.

    Main Methods:

    • Analysis of clinical data from patients with XDR-SP infections.
    • Microbiological characterization of XDR-SP isolates, including antimicrobial susceptibility testing.

    Main Results:

    • Long-term care facility residents with tracheostomies may serve as reservoirs for XDR-SP.
    • Identification of specific characteristics associated with XDR-SP colonization and infection.

    Conclusions:

    • High-risk populations, including those in long-term care facilities, should be considered for pneumococcal vaccination (13- and 23-valent).
    • Judicious use of antimicrobial agents is essential to combat the spread of XDR-SP.
    Keywords:
    South KoreaStreptococcus pneumoniaeantimicrobial drug resistancebacteriaextensively drug-resistant

    More Related Videos

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria14:04

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

    Published on: May 8, 2013

    24.3K
    Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip06:11

    Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip

    Published on: March 29, 2024

    3.0K

    Related Concept Videos

    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
    219
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
    90
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
    84
    Development of Antibiotic Resistance01:30

    Development of Antibiotic Resistance

    Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
    2.0K
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
    24
    Antimicrobial Effectiveness01:28

    Antimicrobial Effectiveness

    The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
    2.3K